The U.S. Food and Drug Administration (FDA) has cleared bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary vaccination. or reinforcement.
The Moderna COVID-19 Vaccine, Bivalent is authorized for use as a single booster dose in people 6 years of age and older.
While the bivalent Pfizer-BioNTech COVID-19 vaccine is authorized for use as a single booster dose in people 5 years of age and older.
Bivalent COVID-19 vaccines include a strain component of the original virus and a component of the Omicron variant.
A bivalent COVID-19 vaccine may also be called an “updated” COVID-19 vaccine booster dose.
COVID-19 vaccines can help protect against serious illness, hospitalization, and death from COVID-19. As the virus changes and your immunity naturally wanes over time, you may lose some of that protection.
Eligibility for a booster with a bivalent COVID-19 vaccine depends on:
•Age
•When you completed your primary vaccination
• When you received your most recent booster dose of a monovalent COVID-19 vaccine
